电工技术学报  2024, Vol. 39 Issue (12): 3855-3868    DOI: 10.19595/j.cnki.1000-6753.tces.231906
高电压与放电 |
等离子体活化介质技术及其生物医学应用
刘定新, 张基珅, 王子丰, 张浩, 郭莉, 周仁武, 王小华, 荣命哲
西安交通大学等离子体生物医学研究中心 西安 710049
Plasma-Activated Media Technology and Its Biomedical Applications
Liu Dingxin, Zhang Jishen, Wang Zifeng, Zhang Hao, Guo Li, Zhou Renwu;, Wang Xiaohua, Rong Mingzhe
Center for Plasma Biomedicine Xi'an Jiaotong University Xi'an 710049 China
全文: PDF (8845 KB)   HTML
输出: BibTeX | EndNote (RIS)      
摘要 等离子体生物医学兴起20余年来,已有多项技术通过美国食品药品监督管理局(FDA)认证并推广应用,但现有的应用方式主要采用等离子体直接处理生命体,存在处理面积小、作用深度浅、有效时间短、稳定性不足等问题,限制了等离子体生物医学的适用范围和应用效果。为此,在近10年研究基础上,发展了等离子体活化介质技术,即:采用等离子体活化处理气体、液体或水凝胶等介质材料,将活性粒子加载到介质材料中再应用,使等离子体生物医学从直接处理变革到间接处理,推动实现“更大面积、更深部位、安全稳定、持续有效”的应用升级。该文总结了等离子体活化介质技术的形成背景与研究现状,分析该技术当前面临的关键科学和技术问题,给出最新研究结果并展望未来发展方向,以期为同行学者和研究生提供参考。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 等离子体生物医学等离子体活化介质活性粒子间接处理    
Abstract:Plasma biomedicine has arisen more than 20 years ago, and multiple technologies have been certified by the united states food and drug administration (FDA) and promoted for application. However, the most widely adopted application method is using plasma to directly treat living organisms, which have problems such as small treatment areas, shallow action depth, short effective time, and insufficient stability, limiting its application scope and effectiveness. Therefore, based on nearly 10 years of research, this paper develops plasma-activated media technology, which uses plasma to activate media such as gas, liquid, or hydrogel to load reactive species into the media. Plasma-activated media technology transforms plasma biomedicine from direct treatment to indirect treatment, and promote supgrading applications with “larger area, deeper site, superior safety and stability, sustained effectiveness”.
However, compared with direct plasma treatment, the addition of media significantly changes the transfer chain of reactive species, causing significant changes in the composition and concentration of reactive species that ultimately act on the lesion. The yield improvement of reactive species from the plasma level, efficient loading of reactive species from the plasma-media interaction level, long-term storage and stable release of reactive species from the media level, and plasma-activated media equipment development from the application level, and optimization of biological and clinical therapeutic effects are problems should be solved. This paper summarizes the background and current status of plasma-activated media technology, as well as the key scientific and technical issues from three aspects: the methods of plasma activation and its optimized designs, the selection of plasma types and working gas, and the selection of media and its performance evaluation. Then, the plasma-activated media prototype equipment and its latest biomedical applications are displayed.
During more than ten years of explorations, studies focus on the generation, loading, storage, release, penetration, and biological effects of reactive species, and various discharge forms and working gases are used to activate three types of media (gas, liquid, and hydrogel). The mode conversion mechanism of air discharge is revealed, and generation efficiency and precise concentration control are improved. The safety evaluation and the effectiveness of key reactive species such as N2O5 are achieved, and various plasma-activated media equipment for biomedical applications is developed. Nonetheless, there is still a lot of work to be done in the future, including: (1) improving biomedical efficacy from the technical level to better meet practical application needs; (2) elucidating the mechanism of biological effect to provide a theoretical foundation for the development of plasma-activated media technology; (3) promoting clinical transformation from the application level to truly serve the cause of people's life and health.
Key wordsPlasma biomedicine    plasma-activated media    reactive species    indirect treatment   
收稿日期: 2023-11-15     
PACS: TM8  
  Q819  
基金资助:国家自然科学基金原创探索计划资助项目(52150221)
通讯作者: 荣命哲 男,1963年生,教授,博士生导师,研究方向为电力开关装备理论与技术,放电等离子体技术。E-mail:mzrong@mail.xjtu.edu.cn   
作者简介: 刘定新 男,1982年生,教授,博士生导师,研究方向为低温等离子体理论与技术、等离子体生物医学技术。E-mail:liudingxin@mail.xjtu.edu.cn
引用本文:   
刘定新, 张基珅, 王子丰, 张浩, 郭莉, 周仁武, 王小华, 荣命哲. 等离子体活化介质技术及其生物医学应用[J]. 电工技术学报, 2024, 39(12): 3855-3868. Liu Dingxin, Zhang Jishen, Wang Zifeng, Zhang Hao, Guo Li, Zhou Renwu;, Wang Xiaohua, Rong Mingzhe. Plasma-Activated Media Technology and Its Biomedical Applications. Transactions of China Electrotechnical Society, 2024, 39(12): 3855-3868.
链接本文:  
https://dgjsxb.ces-transaction.com/CN/10.19595/j.cnki.1000-6753.tces.231906          https://dgjsxb.ces-transaction.com/CN/Y2024/V39/I12/3855